Pharmacodynamic Dose-Response of S-Tenatoprazole-Na (STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers.

Trial Profile

Pharmacodynamic Dose-Response of S-Tenatoprazole-Na (STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 21 Mar 2008

At a glance

  • Drugs Esomeprazole; Tenatoprazole
  • Indications Gastrointestinal disorders
  • Focus Pharmacodynamics
  • Most Recent Events

    • 21 Mar 2008 The expected completion date for this trial is now 1 Nov 2006, as reported by clinicaltrials.gov.
    • 19 May 2007 Status change
    • 19 May 2007 Results have been published.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top